Skip to main content
. 2023 May 3;43(5):369–377. doi: 10.1007/s40261-023-01270-x
First and currently the only disease-modifying therapy
Improves lung function, reduces liver and spleen volume, and increases platelet counts; efficacy sustained through at least 2 years of treatment
Generally well tolerated